02:25 , Apr 14, 2015 |  BC Extra  |  Politics & Policy

Regulators support C-Path's skeletal muscle biomarkers

FDA and EMA issued Letters of Support for four skeletal muscle biomarkers identified by the Predictive Safety Testing Consortium (PSTC) of the Critical Path Institute (C-Path). Elevated levels of myosin light chain 3 ( MYL3),...
08:00 , Dec 4, 2014 |  BC Innovations  |  Tools & Techniques

Roche's heart for diabetes

Building on cardiomyocytes generated from iPS cells by Cellular Dynamics International Inc., Roche scientists have developed a cell-based model of diabetic cardiomyopathy for use in discovery screening.1 The cells have the metabolic and physiological features...